ProfileGDS5678 / 1440444_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 3% 3% 3% 3% 3% 3% 9% 3% 3% 3% 3% 3% 3% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.971173
GSM967853U87-EV human glioblastoma xenograft - Control 21.956153
GSM967854U87-EV human glioblastoma xenograft - Control 31.955253
GSM967855U87-EV human glioblastoma xenograft - Control 41.925793
GSM967856U87-EV human glioblastoma xenograft - Control 51.917693
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.988873
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.238089
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.945553
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.939543
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.955113
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.940433
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.942663
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.954013
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.953573